x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   Forces thwart Pak’s Hamas-style attack on Jammu | In Pak terrorists are given state funerals: Foreign Secretary | Terror nexus exposed: Al-Qaeda backs Pak | Jammu mosques, madrassas open for displaced border residents | Amid cross border shelling, CM Omar reviews situation in border districts | Breeding Ground for fidayeen, links to Hamas, stockpiled NATO arms | PM meets secretaries, stresses on alertness | Masood Azhar’s brother killed: BJP | LG Sinha chairs high-level meeting, reviews preparedness | Army uses Harpy drones to target enemy air defence systems | Pak attempts to attack 15 places in North, Western India foiled | 100 terrorists, aides killed in strikes: Rajnath at All-Party Meeting | SDRF conducts Mock Drill Exercise at IIT Jammu | Developed India strikes back at provocateurs by entering their hideouts: CM Yogi | Cash Row: CJI recommends impeachment of Justice Yashwant Varma, says sources | Amit terms AI as biggest disruptive tech of 21st Century in MZU National Workshop | Salman Sagar appointed as vice provincial president of JKNC | SET exam in J&K, Ladakh UTs postponed | ASCOMS & Hospital to provide free treatment to border shelling victims | Rs 300 crore BrahMos Missile Unit set to be inaugurated in Lucknow on May 11 | Any military attack on India will be met with very firm response: EAM Jaishankar | Vivek Bali Expresses Deep Grief Over Loss of Lives in Poonch Due to Pakistan Shelling | Reasi police foil illegal transportation of Khair logs in Katra area | 84 Bn CRPF Provides Relief to Flood-Affected Families | DC Jammu Reviews Zonal Master Plan for Ramnagar Eco-Sensitive Zone | Horticulture Department Kathua organises exposure visit | DC conducts on site inspection of restoration works on NH-44 | Power shut down in several areas | GMC Doda organises Blood Donation Camp | HPS participates in annual “Save Water, Save Birds” campaign | World Red Cross Day observed at Udhampur | Reasi Administration celebrates World Red Cross Day | ACR reviews implementation of E-Waste Management Action Plan | Poonch Administration steps up restoration of Essential Services, Supplies | Arushi Kotwal of Doda Honoured by Union Minister Dr Mansukh Mandaviya | Mini-Super Bazar M-PACS Maitra inaugurated in Ramban | DC Reasi felicitates JK Board Class 10th 12th Toppers | Back Issues  
 
news details
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
12/28/2022 10:14:27 PM
agencies
HYDERABAD, Dec 28: Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses of Covaxin, reported Press Trust of India.
Dr Vikram Paradkar, Executive Vice President (Manufacturing), Biological E, said the firm produced about 30 crore doses of Corbevax in total, abiding by the vaccine manufacturing commitment to the Central government.
In March '22, Biological E successfully supplied 10 crore doses to the government.
"Currently, we have approximately 20 crore (200 million) doses that are fully tested and ready for supply, as and when we receive orders. Additionally, we manufactured 20 crore doses equivalent of the antigen which will help us ramp up the manufacturing of the Corbevax finished product quickly," Vikram Paradkar told Press Trust of India.
The vaccine has been developed by Biological E in collaboration with Texas Children's Hospital Center for Vaccine Development (Texas Children's CVD) and Baylor College of Medicine (Baylor) in Houston, Texas, USA.
He further said Biological E can begin with the additional vaccine supplies within eight weeks of future orders and can manufacture and supply approximately 10 crore doses of Corbevax on a monthly basis as per its qualified manufacturing capacity.
Bharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses as drug substance.
"Additional production capacity is also available to meet product demand," they said adding fresh stocks of the vaccine are available and ready for supplies.
Covaxin, India's indigenous COVID-19 vaccine, was developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Due to lack of product demand, production stoppage of Covaxin was initiated earlier this year and also the 50 million doses in vials are set to expire during early 2023, resulting in losses to the company, sources had earlier said.
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
 
Early Times Android App
STOCK UPDATE
  
BSE Sensex
NSE Nifty
 
CRICKET UPDATE
 
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU